You are now leaving this website. By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co Inc, Rahway, NJ USA.
You are now leaving this website. By continuing, you will be directed to a site intended only for residents of the United States and Canada. We are called MSD everywhere, except in the United States and Canada where we are known as Merck & Co., Inc., Rahway, NJ, USA.
MSD Biotech, Dublin is looking for innovative thinkers to shape the future of biotech in Ireland
The facility will push the boundaries of science and offer team members the opportunity to discover new medicines that treat the world’s most significant health challenges and benefit patients globally.
A state-of-art facility for a company that's committed to research
MSD Biotech, Dublin will be MSD’s first ever Large-Scale Mammalian-Based Drug Substance Facility, with the mission and ambition to manufacture breakthrough medicines from Ireland for patients around the world.
Get ready to be part of a bigger story in the world
This facility will be a significant supplier of drug substances for one of MSD’s key treatments and will also be critical in the future supply of new biotechnology products to its global network. We are assembling a dynamic, motivated, high-performing group to play a pivotal role in the manufacture of MSD’s biologics-based medicines, including in the area of immuno-oncology.
Discover the work we do and how we shape the future of biotech globally
Explore our other sites
Brinny, Co. Cork
This site has been a vibrant part of the pharmaceutical sector in Cork for over 35 years. With a successful legacy of developing and commercially supplying biotech products, Brinny is now specialising in the development and manufacture of innovative novel vaccines and testing of immuno-oncology medicines.
Opened in 1976 and currently employs 500 highly skilled people. The site has API and Formulation facilities for the manufacture and the development of new products. Work relating to 20 of MSD’s pipeline products is undertaken at this state-of-the-art research and commercialisation facility.
Opened in 2008 as MSD’s first vaccines facility outside of the US. Carlow is the filling site for the liquid form of our immuno-oncology treatment for the global market. We are currently working on the construction of a second manufacturing facility that will focus on the production of vaccines and biologics.
The base for our Animal Health and Human Health businesses as well as a number of global and national support services including Clinical Research, Medical Affairs, Regulatory Affairs, Sales, Policy & Communications and Marketing.
The latest addition to the MSD, Ireland family is Dunboyne which joined our network in September 2020. With a team of over 200, this site will be MSD’s first Biologics Drug Substance single use commercialization facility, playing an important role in helping us commercialise key medicines.